Apolipoprotein AI-CIII gene polymorphisms in Japanese myocardial infarction survivors. 1987

J Satoh, and N Hattori, and M Onuki, and K Yamakawa, and H Fujiwara, and H Amamiya, and H Nagaoka, and T Sakuma, and Y Yamanouchi, and T Okafuji

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D005796 Genes A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms. Cistron,Gene,Genetic Materials,Cistrons,Genetic Material,Material, Genetic,Materials, Genetic
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001054 Apolipoproteins A Structural proteins of the alpha-lipoproteins (HIGH DENSITY LIPOPROTEINS), including APOLIPOPROTEIN A-I and APOLIPOPROTEIN A-II. They can modulate the activity of LECITHIN CHOLESTEROL ACYLTRANSFERASE. These apolipoproteins are low in atherosclerotic patients. They are either absent or present in extremely low plasma concentration in TANGIER DISEASE. Apo-A,ApoA
D001056 Apolipoproteins C A group of apolipoproteins that can readily exchange among the various classes of lipoproteins (HDL; VLDL; CHYLOMICRONS). After lipolysis of TRIGLYCERIDES on VLDL and chylomicrons, Apo-C proteins are normally transferred to HDL. The subtypes can modulate remnant binding to receptors, LECITHIN CHOLESTEROL ACYLTRANSFERASE, or LIPOPROTEIN LIPASE. Apo-C,Apo C,ApoC,Apoprotein (C),Apoproteins C

Related Publications

J Satoh, and N Hattori, and M Onuki, and K Yamakawa, and H Fujiwara, and H Amamiya, and H Nagaoka, and T Sakuma, and Y Yamanouchi, and T Okafuji
June 1986, Molecular biology & medicine,
J Satoh, and N Hattori, and M Onuki, and K Yamakawa, and H Fujiwara, and H Amamiya, and H Nagaoka, and T Sakuma, and Y Yamanouchi, and T Okafuji
June 1994, The Clinical investigator,
J Satoh, and N Hattori, and M Onuki, and K Yamakawa, and H Fujiwara, and H Amamiya, and H Nagaoka, and T Sakuma, and Y Yamanouchi, and T Okafuji
February 2007, Journal of digestive diseases,
J Satoh, and N Hattori, and M Onuki, and K Yamakawa, and H Fujiwara, and H Amamiya, and H Nagaoka, and T Sakuma, and Y Yamanouchi, and T Okafuji
October 1995, Zhonghua yi xue za zhi,
J Satoh, and N Hattori, and M Onuki, and K Yamakawa, and H Fujiwara, and H Amamiya, and H Nagaoka, and T Sakuma, and Y Yamanouchi, and T Okafuji
February 1992, Human genetics,
J Satoh, and N Hattori, and M Onuki, and K Yamakawa, and H Fujiwara, and H Amamiya, and H Nagaoka, and T Sakuma, and Y Yamanouchi, and T Okafuji
January 2000, Medical science monitor : international medical journal of experimental and clinical research,
J Satoh, and N Hattori, and M Onuki, and K Yamakawa, and H Fujiwara, and H Amamiya, and H Nagaoka, and T Sakuma, and Y Yamanouchi, and T Okafuji
August 2011, European journal of internal medicine,
J Satoh, and N Hattori, and M Onuki, and K Yamakawa, and H Fujiwara, and H Amamiya, and H Nagaoka, and T Sakuma, and Y Yamanouchi, and T Okafuji
April 1997, The Journal of clinical investigation,
J Satoh, and N Hattori, and M Onuki, and K Yamakawa, and H Fujiwara, and H Amamiya, and H Nagaoka, and T Sakuma, and Y Yamanouchi, and T Okafuji
November 1986, Lancet (London, England),
J Satoh, and N Hattori, and M Onuki, and K Yamakawa, and H Fujiwara, and H Amamiya, and H Nagaoka, and T Sakuma, and Y Yamanouchi, and T Okafuji
November 1986, Nucleic acids research,
Copied contents to your clipboard!